Related Experiment Videos
Bombesin ameliorates colonic damage in experimental colitis.
B M Güllüoğlu1, H Kurtel, M G Güllüoğlu
1Marmara University School of Medicine, Department of General Surgery, Turkey.
Digestive Diseases and Sciences
|September 24, 1999
Summary
Bombesin administration reduced colon damage in rats with experimentally induced colitis. This peptide shows potential for protecting gut integrity and treating inflammatory bowel disease.
Area of Science:
- Gastroenterology
- Pharmacology
- Inflammation Research
Background:
- Inflammatory Bowel Disease (IBD) presents a significant clinical challenge.
- Current treatments for colitis have limitations.
- Novel therapeutic agents are needed to protect gut integrity.
Purpose of the Study:
- To investigate the therapeutic potential of bombesin in a rat model of colitis.
- To evaluate bombesin's effect on colon inflammation and injury.
- To assess bombesin's impact on mucosal proliferation.
Main Methods:
- Colitis was induced in rats using 2,4,6-trinitrobenzene sulfonic acid (TNBS).
- Bombesin (10 microg/kg) or vehicle was administered subcutaneously three times daily for 14 days.
- Colonic damage, myeloperoxidase (MPO) levels, and plasma carbonyl content were assessed.
Main Results:
- TNBS-induced colitis resulted in severe macroscopic and microscopic inflammatory changes.
- Bombesin treatment significantly attenuated TNBS-induced colonic damage.
- Bombesin administration promoted histopathologically apparent mucosal proliferation.
Conclusions:
- Bombesin exhibits protective effects against experimental colitis in rats.
- Bombesin may play a role in preserving gut integrity.
- Further research into bombesin as a therapeutic agent for IBD is warranted.